Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
20 nov. 2024 16h30 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) is proud to announce the publication of a pivotal research article in the prestigious...
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
25 sept. 2024 09h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) provides the following update: Dear...
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
18 juin 2024 10h35 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient,...
Sirona Biochem Engages Stonegate Healthcare Partners
07 mai 2024 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced a partnership with Stonegate Healthcare Partners. Stonegate is a...
SIRONA BIOCHEM Corporate Update April 2024
08 avr. 2024 02h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) provides the following update: Dear...
Sirona Biochem Announces Close of Private Placement
04 avr. 2024 21h24 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Vancouver, British Columbia – April 4, 2024 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (“Sirona”) has closed its private...
Sirona Biochem Announces 2023 Annual Meeting Results
28 mars 2024 17h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces the voting results from its Annual General Meeting of...
Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
13 mars 2024 09h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announces a significant achievement in its quest...
Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025
21 févr. 2024 09h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF), also known as Sirona, is excited to share a new milestone in its journey....
Sirona Biochem Provides Update on Loan
15 févr. 2024 17h50 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announce that, further to its news release on...